Kenvue: Empowering Wellness Through Everyday Care

Kenvue Inc., established in 2022 as the consumer health division of Johnson & Johnson, is dedicated to enhancing well-being through trusted brands and innovative solutions. With a portfolio that includes Tylenol, Neutrogena, Listerine, Band-Aid, and Zyrtec, Kenvue serves approximately 1.2 billion consumers globally.

A Legacy of Trust and Innovation

With over 135 years of experience, Kenvue has built a reputation for delivering safe and effective products. The company's commitment to science and quality has earned the trust of consumers worldwide.

Core Values Guiding Kenvue

Putting People First: Kenvue prioritizes integrity and quality, ensuring that every decision and action benefits consumers and communities.

Caring Fiercely: The company fosters an inclusive environment, encouraging collaboration to deliver the best possible care.

Earning Trust with Science: Kenvue leverages leading science to develop products that empower consumers, maintaining trust through continuous innovation.

Solving with Courage: The company addresses unmet needs with empathy and bold solutions, striving to improve lives through innovative products.

Global Presence and Impact

Kenvue's extensive portfolio includes brands such as Aveeno, Band-Aid, Benadryl, Johnson's Baby, Listerine, Neutrogena, Tylenol, and Zyrtec. These products are available in numerous countries, reflecting Kenvue's dedication to global wellness. 

Looking Ahead

As a publicly traded company, Kenvue continues to focus on innovation and consumer trust. The company's mission remains centered on providing everyday care that empowers individuals to lead healthier, more fulfilling lives.